Phyllis Gotlib Sells 4,958 Shares of American Well Corporation (NYSE:AMWL) Stock

American Well Corporation (NYSE:AMWL - Get Free Report) insider Phyllis Gotlib sold 4,958 shares of the business's stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $8.63, for a total value of $42,787.54. Following the completion of the sale, the insider directly owned 136,891 shares in the company, valued at approximately $1,181,369.33. The trade was a 3.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Phyllis Gotlib also recently made the following trade(s):

• On Monday, June 2nd, Phyllis Gotlib sold 4,782 shares of American Well stock. The shares were sold at an average price of $6.61, for a total value of $31,609.02.

American Well Stock Performance

American Well stock traded down $0.08 during midday trading on Friday, hitting $8.51. 31,169 shares of the company's stock were exchanged, compared to its average volume of 72,968. The stock has a market cap of $132.84 million, a price-to-earnings ratio of -0.84 and a beta of 1.29. American Well Corporation has a 12-month low of $6.00 and a 12-month high of $12.95. The firm's 50 day simple moving average is $7.25 and its 200 day simple moving average is $8.25.

American Well (NYSE:AMWL - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported ($1.73) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.09) by $1.36. The firm had revenue of $66.83 million for the quarter, compared to analyst estimates of $60.15 million. American Well had a negative return on equity of 48.36% and a negative net margin of 59.13%. On average, equities research analysts forecast that American Well Corporation will post -9.34 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Geode Capital Management LLC grew its position in American Well by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 147,925 shares of the company's stock valued at $1,073,000 after buying an additional 922 shares during the last quarter. Northern Trust Corp lifted its position in American Well by 7.4% in the fourth quarter. Northern Trust Corp now owns 29,021 shares of the company's stock valued at $210,000 after purchasing an additional 1,992 shares during the period. Two Sigma Investments LP lifted its position in American Well by 12.3% in the fourth quarter. Two Sigma Investments LP now owns 19,216 shares of the company's stock valued at $139,000 after purchasing an additional 2,102 shares during the period. Jane Street Group LLC boosted its holdings in American Well by 21.9% in the 4th quarter. Jane Street Group LLC now owns 19,260 shares of the company's stock valued at $140,000 after purchasing an additional 3,462 shares in the last quarter. Finally, Sapient Capital LLC acquired a new position in American Well during the 1st quarter worth approximately $79,000. Institutional investors and hedge funds own 56.05% of the company's stock.

Analysts Set New Price Targets

AMWL has been the topic of a number of recent analyst reports. Piper Sandler reissued a "neutral" rating and set a $8.00 target price (down previously from $10.00) on shares of American Well in a research report on Friday, May 23rd. Truist Financial dropped their target price on shares of American Well from $12.00 to $7.50 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Stifel Nicolaus reduced their price target on shares of American Well from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Friday, May 2nd. UBS Group dropped their price objective on American Well from $12.00 to $9.00 and set a "neutral" rating on the stock in a report on Thursday, May 8th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of American Well in a research report on Friday, May 2nd. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Hold" and a consensus target price of $9.67.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.